Clinical trial
Discharge Medication Use Post-Operatively in GU Cancer Patients
NCT06795087 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discharge Medication Use Post-Operatively in GU Cancer Patients
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 21, 2025
- Completion date
- July 31, 2027
- Enrollment
- 684 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
genitourinary cancer